Since ANXA2 has been shown to be a vital part of specific molecular pathways characteristic of tumors’ molecular signatures, further could eventually improve the diagnosis, prognosis, and treatment of many neoplasms of the DS. This evidence concerns the gene ANXA2 and neoplasm.